Suchergebnisse - "Brown, Jennifer R"

PubPharm (5)

1

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The lancet / Oncology | 2017

von Zelenetz, A. | Barrientos, J. | Brown, J. | +20

2

Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The lancet / Oncology | 2017

von Zelenetz, A. | Barrientos, J. | Brown, J. | +20

3

Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study

enthalten in: The lancet / Oncology | 2016

von O'Brien, S. | Jones, J. | Coutre, S. | +18

4

Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study

enthalten in: The lancet / Oncology | 2016

von O'Brien, S. | Jones, J. | Coutre, S. | +18

5

A new era of treatment for chronic lymphocytic leukaemia?

enthalten in: The lancet / Oncology | 2014

von Brown, J.

1
[1]